about
Patient counseling increases postpartum follow-up in women with gestational diabetes mellitusTreating mild gestational diabetes mellitus: a cost-effectiveness analysis.The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.Preference toward future mode of delivery: how do antepartum preferences and prior delivery experience contribute?Gastroschisis: mortality risks with each additional week of expectant management.The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality.Down syndrome: perinatal mortality risks with each additional week of expectant management.How do maternal views of delivery outcomes vary by demographics and preferred mode of delivery?Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?Does risk of preeclampsia differ by twin chorionicity?The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus.Racial/ethnic variations in perineal length and association with perineal lacerations: a prospective cohort study.Fundal height: a useful screening tool for fetal growth?Utility of chromosomal microarray in anomalous fetuses.283: Congenital anomalies in twin versus triplet pregnancies613: Maternal and fetal/neonatal outcomes in twin versus triplet pregnancies123: Preexisting maternal depression confers increased risk of neonatal morbidity124: Is depression a predictor of cesarean delivery?232: Prenatally diagnosed congenital diaphragmatic hernia: How can microarray inform prognosis?284: Preexisting depression confers increased risk of maternal morbidity324: The utility of chromosomal microarray in predicting neonatal outcomes in the setting of fetal malformations374: Oligohydramnios: risks of stillbirth and infant death439: Mortality risk of common cardiac anomalies in down syndrome558: Gastroschisis: what is the risk of fetal demise and infant death with each additional week of expectant management?559: Periviable twins versus singletons: how do neonatal outcomes compare?698: Late entrants to prenatal care & increased mortality717: Down syndrome: what are the risks of stillbirth and adverse neonatal outcomes?724: Third-trimester growth ultrasound vs fundal height screening for small for gestational age: a decision analysis129: Non-invasive prenatal testing versus standard first- and second-trimester screening for the diagnosis of aneuploidy in women of advanced maternal age197: Neonatal outcomes at periviable gestational ages: does half a week make a difference?390: Health care costs of subchromosomal deletion and duplication syndromes compared to aneuploidy syndromes in the first years of life423: Routine antenatal testing for pregnancies at 40 weeks gestation: a cost-effectiveness analysis505: Preference toward mode of delivery in the future: how do recent delivery experience and antepartum desires contribute?728: Vaginal versus cesarean delivery for breech in late preterm: how do neonatal outcomes compare?94: What is the optimal time to deliver dichorionic diamniotic twins when one twin has intrauterine growth restriction?296: Women with gestational diabetes and prior shoulder dystocia: what is the optimal mode of delivery?133: Median costs and outcomes related to multiple gestations166: Predictors of cesarean delivery in women undergoing labor induction with a Foley balloon574: Median costs and outcomes related to hypertensive disease in pregnancyLabor Induction With a Foley Balloon Inflated to 30 mL Compared With 60 mL
P50
Q36182577-409ACA05-5ECF-4EDB-A804-BB6427E8CD0FQ36238785-132FBA99-902F-4CE9-82AD-E4EA37E92004Q36843894-0BC6B6C1-DCAF-4703-B047-31DE23981B2CQ39130662-98F38EB8-F7A7-40ED-AA2C-1A9296B17387Q39421237-DCABB1F7-03A1-4502-B015-04EA1E793D61Q39774687-8F6F54A5-8F01-4588-A05A-3D032C892BEAQ39986794-049E8BD8-014A-4929-B983-EAF60AD8A4CAQ41677238-A3C6B837-87F1-40AA-99D8-2E1DB6412E84Q46037605-161DCE8E-41CC-481B-BC8B-FFA6F6F57B07Q46213486-74151C81-2C58-40AF-8CB7-D19B6B85AEE0Q46463715-557A1645-0A8A-4F05-A742-0585926B43D9Q46619290-4B7B9D7E-0AEA-4FC1-8ED8-7FAF64806511Q47414147-19CA1F85-5CA1-4B7E-953A-C57304AC8420Q48317769-C37FE849-CE7A-485D-BB14-3E4480531BC9Q60207783-B1E86F61-509D-4F13-A4C6-0EFD79BB7566Q60207804-8F57C37B-98F4-4E1C-AE2A-A4B8ED1A60F4Q60207810-A3DBB0BC-76A8-404B-B6B4-09B961086253Q60207817-4E6C6FE7-1C30-43B4-AAE7-9E774204BA95Q60207824-2E9279FA-F038-473C-888A-6E1BADC22B5CQ60207833-D8B2E5A4-F565-492D-B709-571DB118AA15Q60207839-E5D1B146-CD2D-46B7-B09D-6CBB29FDA8B6Q60207846-BCCB5F59-8AF5-4E4D-A371-FB719575259BQ60207853-CA6D233A-FA4F-447E-994C-EDC46DA8935EQ60207859-2823A510-2989-473C-AE19-CF4636A319A2Q60207866-89D0A31C-DFB2-4EE3-A8D8-9844DE33AC7DQ60207872-29D3F495-0FEE-4BAE-BC3B-6F35353E04AAQ60207880-2FC1228B-5243-42AA-97A6-6E60065C666EQ60207885-2F408794-067A-4832-9EB1-AE2C751EE341Q60207913-EA027391-A769-4EA8-A404-4CFFC7EBB36BQ60207919-F368672D-10CE-42AE-B467-F8FCF2D90B02Q60207926-198270AC-6CE1-435A-AADB-AD6C63C82F82Q60207932-45391B30-6950-4A9B-BDD7-F5EE6FE375CCQ60207939-52888AAC-CF37-4D29-889F-53AAA791F4D0Q60207945-C03214AD-B2DD-4389-94D7-979E5DEF02FEQ60207965-F544D582-8573-42EA-ADC5-02803AE363B2Q60207984-387A7791-4F34-45D9-B106-55454A63F4EDQ60208016-A71AF51E-F91C-48E1-9813-6AE0DB9B3F43Q60208028-7C38B81A-2433-421F-AED6-0F012C047C87Q60208035-051F940C-A682-4B62-B7BC-28855E65DE59Q60208059-F2BB3853-9F49-4432-81CA-262C588AF1CB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Teresa N Sparks
@ast
Teresa N Sparks
@en
Teresa N Sparks
@es
Teresa N Sparks
@nl
Teresa N Sparks
@sl
type
label
Teresa N Sparks
@ast
Teresa N Sparks
@en
Teresa N Sparks
@es
Teresa N Sparks
@nl
Teresa N Sparks
@sl
prefLabel
Teresa N Sparks
@ast
Teresa N Sparks
@en
Teresa N Sparks
@es
Teresa N Sparks
@nl
Teresa N Sparks
@sl
P106
P21
P31
P496
0000-0002-8593-2186